Broadcom Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Broadcom Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Nov 4, 2018 | $5.44B | Dec 21, 2018 |
| FY2018 | Aug 5, 2018 | $5.06B | Dec 21, 2018 |
| FY2018 | May 6, 2018 | $5.01B | Dec 21, 2018 |
| FY2018 | Feb 4, 2018 | $5.33B | Dec 21, 2018 |
| FY2018 | Oct 29, 2017 | $4.84B | Dec 21, 2018 |
| FY2018 | Jul 30, 2017 | $4.46B | Dec 21, 2018 |
| FY2018 | Apr 30, 2017 | $4.19B | Dec 21, 2018 |
| FY2018 | Jan 29, 2017 | $4.14B | Dec 21, 2018 |
| FY2018 | Oct 30, 2016 | $13.24B | Dec 21, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $63.89B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $51.57B | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $35.82B | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $33.20B | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $27.45B | Dec 14, 2023 |
| FY2020 | Nov 1, 2020 | $6.47B | Dec 18, 2020 |
| FY2020 | Aug 2, 2020 | $5.82B | Dec 18, 2020 |
| FY2020 | May 3, 2020 | $5.74B | Dec 18, 2020 |
| FY2020 | Feb 2, 2020 | $5.86B | Dec 18, 2020 |
| FY2020 | Nov 3, 2019 | $5.78B | Dec 18, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $43.29B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $32.51B | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $24.69B | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $22.10B | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $16.84B | Dec 14, 2023 |
| FY2020 | Nov 1, 2020 | $3.75B | Dec 18, 2020 |
| FY2020 | Aug 2, 2020 | $3.32B | Dec 18, 2020 |
| FY2020 | May 3, 2020 | $3.19B | Dec 18, 2020 |
| FY2020 | Feb 2, 2020 | $3.26B | Dec 18, 2020 |
| FY2020 | Nov 3, 2019 | $3.15B | Dec 18, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Nov 3, 2024 | $5.90B | Dec 20, 2024 |
| FY2024 | Oct 29, 2023 | $14.08B | Dec 20, 2024 |
| FY2024 | Oct 30, 2022 | $11.50B | Dec 20, 2024 |
| FY2018 | Nov 4, 2018 | $1.12B | Dec 21, 2018 |
| FY2018 | Aug 5, 2018 | $1.20B | Dec 21, 2018 |
| FY2018 | May 6, 2018 | $3.72B | Dec 21, 2018 |
| FY2018 | Feb 4, 2018 | $6.23B | Dec 21, 2018 |
| FY2018 | Oct 29, 2017 | $532.00M | Dec 21, 2018 |
| FY2018 | Jul 30, 2017 | $481.00M | Dec 21, 2018 |
| FY2018 | Apr 30, 2017 | $440.00M | Dec 21, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $25.48B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $13.46B | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $16.21B | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $14.23B | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $8.52B | Dec 14, 2023 |
| FY2020 | Nov 1, 2020 | $1.53B | Dec 18, 2020 |
| FY2020 | Aug 2, 2020 | $1.01B | Dec 18, 2020 |
| FY2020 | May 3, 2020 | $766.00M | Dec 18, 2020 |
| FY2020 | Feb 2, 2020 | $714.00M | Dec 18, 2020 |
| FY2020 | Nov 3, 2019 | $1.05B | Dec 18, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $10.98B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $9.31B | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $5.25B | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $4.92B | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $4.85B | Dec 14, 2023 |
| FY2022 | Nov 1, 2020 | $4.97B | Dec 16, 2022 |
| FY2021 | Nov 3, 2019 | $4.70B | Dec 17, 2021 |
| FY2020 | Nov 4, 2018 | $3.77B | Dec 18, 2020 |
| FY2019 | Oct 29, 2017 | $3.30B | Dec 20, 2019 |
| FY2018 | Oct 30, 2016 | $2.67B | Dec 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $4.21B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $4.96B | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $1.59B | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $1.38B | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $1.35B | Dec 14, 2023 |
| FY2022 | Nov 1, 2020 | $1.94B | Dec 16, 2022 |
| FY2021 | Nov 3, 2019 | $1.71B | Dec 17, 2021 |
| FY2020 | Nov 4, 2018 | $1.06B | Dec 18, 2020 |
| FY2019 | Oct 29, 2017 | $789.00M | Dec 20, 2019 |
| FY2018 | Oct 30, 2016 | $806.00M | Dec 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $27.54B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $19.96B | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $18.09B | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $16.74B | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $13.76B | Dec 14, 2023 |
| FY2022 | Nov 1, 2020 | $12.06B | Dec 16, 2022 |
| FY2021 | Nov 3, 2019 | $9.70B | Dec 17, 2021 |
| FY2020 | Nov 4, 2018 | $8.88B | Dec 18, 2020 |
| FY2019 | Oct 29, 2017 | $6.55B | Dec 20, 2019 |
| FY2018 | Oct 30, 2016 | $3.41B | Dec 21, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $623.00M | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $548.00M | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $452.00M | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $424.00M | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $443.00M | Dec 14, 2023 |
| FY2022 | Nov 1, 2020 | $463.00M | Dec 16, 2022 |
| FY2021 | Nov 3, 2019 | $432.00M | Dec 17, 2021 |
| FY2020 | Nov 4, 2018 | $635.00M | Dec 18, 2020 |
| FY2019 | Oct 29, 2017 | $1.07B | Dec 20, 2019 |
| FY2018 | Oct 30, 2016 | $723.00M | Dec 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $171.09B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $165.65B | Dec 18, 2025 |
| FY2024 | Oct 29, 2023 | $72.86B | Dec 20, 2024 |
| FY2023 | Oct 30, 2022 | $73.25B | Dec 14, 2023 |
| FY2022 | Oct 31, 2021 | $75.57B | Dec 16, 2022 |
| FY2021 | Nov 1, 2020 | $75.93B | Dec 17, 2021 |
| FY2020 | Nov 3, 2019 | $67.49B | Dec 18, 2020 |
| FY2019 | Nov 4, 2018 | $50.12B | Dec 20, 2019 |
| FY2018 | Oct 29, 2017 | $54.42B | Dec 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $89.80B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $97.97B | Dec 18, 2025 |
| FY2024 | Oct 29, 2023 | $48.87B | Dec 20, 2024 |
| FY2023 | Oct 30, 2022 | $50.54B | Dec 14, 2023 |
| FY2022 | Oct 31, 2021 | $50.58B | Dec 16, 2022 |
| FY2021 | Nov 1, 2020 | $52.03B | Dec 17, 2021 |
| FY2020 | Nov 3, 2019 | $42.52B | Dec 18, 2020 |
| FY2019 | Nov 4, 2018 | $23.47B | Dec 20, 2019 |
| FY2018 | Oct 29, 2017 | $31.23B | Dec 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Nov 3, 2019 | $24.94B | Dec 20, 2019 |
| FY2019 | Nov 4, 2018 | $26.66B | Dec 20, 2019 |
| FY2018 | Oct 29, 2017 | $20.29B | Dec 21, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $97.80B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $97.87B | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $43.65B | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $43.61B | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $43.45B | Dec 14, 2023 |
| FY2022 | Nov 1, 2020 | $43.45B | Dec 16, 2022 |
| FY2021 | Nov 3, 2019 | $36.71B | Dec 17, 2021 |
| FY2020 | Nov 4, 2018 | $26.91B | Dec 18, 2020 |
| FY2019 | Oct 29, 2017 | $24.71B | Dec 20, 2019 |
| FY2018 | Oct 30, 2016 | $24.73B | Dec 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $9.76B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $0 | Dec 18, 2025 |
| FY2024 | Oct 29, 2023 | $2.68B | Dec 20, 2024 |
| FY2023 | Oct 30, 2022 | $1.60B | Dec 14, 2023 |
| FY2022 | Oct 31, 2021 | $748.00M | Dec 16, 2022 |
| FY2021 | Nov 1, 2020 | $0 | Dec 17, 2021 |
| FY2020 | Nov 3, 2019 | $0 | Dec 18, 2020 |
| FY2019 | Nov 4, 2018 | $3.49B | Dec 20, 2019 |
| FY2018 | Oct 29, 2017 | ($129.00M) | Dec 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $16.18B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $9.35B | Dec 18, 2025 |
| FY2024 | Oct 29, 2023 | $14.19B | Dec 20, 2024 |
| FY2023 | Oct 30, 2022 | $12.42B | Dec 14, 2023 |
| FY2022 | Oct 31, 2021 | $12.16B | Dec 16, 2022 |
| FY2021 | Nov 1, 2020 | $7.62B | Dec 17, 2021 |
| FY2021 | Nov 3, 2019 | $5.06B | Dec 17, 2021 |
| FY2021 | Nov 4, 2018 | $4.29B | Dec 17, 2021 |
| FY2020 | Oct 29, 2017 | $11.20B | Dec 18, 2020 |
| FY2019 | Oct 30, 2016 | $3.10B | Dec 20, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Oct 31, 2021 | $39.67B | Dec 17, 2021 |
| FY2021 | Nov 1, 2020 | $40.99B | Dec 17, 2021 |
| FY2019 | Nov 3, 2019 | $32.80B | Dec 20, 2019 |
| FY2019 | Nov 4, 2018 | $17.49B | Dec 20, 2019 |
| FY2018 | Oct 29, 2017 | $17.55B | Dec 21, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | 4 | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | 1 | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | 3 | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | 2 | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | 15 | Dec 14, 2023 |
| FY2022 | Nov 1, 2020 | 6 | Dec 16, 2022 |
| FY2021 | Nov 3, 2019 | 6 | Dec 17, 2021 |
| FY2020 | Nov 4, 2018 | 29 | Dec 18, 2020 |
| FY2019 | Oct 29, 2017 | 4 | Dec 20, 2019 |
| FY2018 | Oct 30, 2016 | (4) | Dec 21, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | 4 | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | 1 | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | 3 | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | 2 | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | 15 | Dec 14, 2023 |
| FY2020 | Nov 1, 2020 | 2 | Dec 18, 2020 |
| FY2020 | Aug 2, 2020 | 1 | Dec 18, 2020 |
| FY2020 | May 3, 2020 | 1 | Dec 18, 2020 |
| FY2020 | Feb 2, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Nov 3, 2019 | 1 | Dec 18, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | 4.74B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | 4.69B | Dec 18, 2025 |
| FY2024 | Oct 29, 2023 | 4.14B | Dec 20, 2024 |
| FY2023 | Oct 30, 2022 | 418.00M | Dec 14, 2023 |
| FY2022 | Oct 31, 2021 | 413.00M | Dec 16, 2022 |
| FY2021 | Nov 1, 2020 | 407.00M | Dec 17, 2021 |
| FY2020 | Nov 3, 2019 | 398.00M | Dec 18, 2020 |
| FY2019 | Nov 4, 2018 | 407.64M | Dec 20, 2019 |
| FY2018 | Oct 29, 2017 | 408.73M | Dec 21, 2018 |
| FY2018 | Feb 1, 2016 | 390.00M | Dec 21, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 2, 2025 | $11.14B | Dec 18, 2025 |
| FY2025 | Nov 3, 2024 | $9.81B | Dec 18, 2025 |
| FY2025 | Oct 29, 2023 | $7.65B | Dec 18, 2025 |
| FY2024 | Oct 30, 2022 | $6.73B | Dec 20, 2024 |
| FY2023 | Oct 31, 2021 | $5.91B | Dec 14, 2023 |
| FY2022 | Nov 1, 2020 | $5.24B | Dec 16, 2022 |
| FY2021 | Nov 3, 2019 | $4.24B | Dec 17, 2021 |
| FY2020 | Nov 4, 2018 | $2.92B | Dec 18, 2020 |
| FY2019 | Oct 29, 2017 | $1.65B | Dec 20, 2019 |
| FY2018 | Oct 30, 2016 | $716.00M | Dec 21, 2018 |